Literature DB >> 19691486

A non-reactive glutamine residue of alpha2-antiplasmin promotes interactions with the factor XIII active site region.

D B Cleary, P G Doiphode, T M Sabo, M C Maurer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19691486      PMCID： PMC4685669          DOI： 10.1111/j.1538-7836.2009.03583.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  12 in total

1.  Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA.

Authors:  Yoshiaki Sugimura; Masayo Hosono; Fumitaka Wada; Tohru Yoshimura; Masatoshi Maki; Kiyotaka Hitomi
Journal:  J Biol Chem       Date:  2006-04-24       Impact factor: 5.157

2.  Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin.

Authors:  B J Backes; J L Harris; F Leonetti; C S Craik; J A Ellman
Journal:  Nat Biotechnol       Date:  2000-02       Impact factor: 54.908

3.  Characterizing the specificity of activated Factor XIII for glutamine-containing substrate peptides.

Authors:  David B Cleary; Muriel C Maurer
Journal:  Biochim Biophys Acta       Date:  2006-05-23

Review 4.  Transdab wiki: the interactive transglutaminase substrate database on web 2.0 surface.

Authors:  Eva Csosz; Bertalan Meskó; László Fésüs
Journal:  Amino Acids       Date:  2008-07-02       Impact factor: 3.520

5.  Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma.

Authors:  K Bangert; A H Johnsen; U Christensen; S Thorsen
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

6.  Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).

Authors:  H Ritchie; L C Lawrie; P W Crombie; M W Mosesson; N A Booth
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

Review 7.  Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance.

Authors:  Carla Esposito; Ivana Caputo
Journal:  FEBS J       Date:  2005-02       Impact factor: 5.542

8.  Expression, purification, and characterization of human factor XIII in Saccharomyces cerevisiae.

Authors:  P D Bishop; D C Teller; R A Smith; G W Lasser; T Gilbert; R L Seale
Journal:  Biochemistry       Date:  1990-02-20       Impact factor: 3.162

9.  Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme.

Authors:  J J Gorman; J E Folk
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

10.  Molecular mechanism of the interaction between activated factor XIII and its glutamine donor peptide substrate.

Authors:  K Pénzes; K E Kövér; F Fazakas; G Haramura; L Muszbek
Journal:  J Thromb Haemost       Date:  2009-01-17       Impact factor: 5.824
View more
  2 in total

1.  Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.

Authors:  Prakash G Doiphode; Marina V Malovichko; Kelly Njine Mouapi; Muriel C Maurer
Journal:  Anal Biochem       Date:  2014-04-19       Impact factor: 3.365

2.  Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.

Authors:  Kelly Njine Mouapi; Jacob D Bell; Kerrie A Smith; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  Blood       Date:  2016-03-07       Impact factor: 22.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.